- Home
- QURE vs XFLT Comparison
QURE vs XFLT Comparison
Compare QURE & XFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- XFLT
- Stock Information
- Founded
- QURE 1998
- XFLT 2017
- Country
- QURE Netherlands
- XFLT United States
- Employees
- QURE N/A
- XFLT N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- XFLT Investment Managers
- Sector
- QURE Health Care
- XFLT Finance
- Exchange
- QURE Nasdaq
- XFLT Nasdaq
- Market Cap
- QURE 432.6M
- XFLT 380.6M
- IPO Year
- QURE 2007
- XFLT N/A
- Fundamental
- Price
- QURE $6.65
- XFLT $6.82
- Analyst Decision
- QURE Buy
- XFLT
- Analyst Count
- QURE 6
- XFLT 0
- Target Price
- QURE $19.50
- XFLT N/A
- AVG Volume (30 Days)
- QURE 846.7K
- XFLT 336.2K
- Earning Date
- QURE 11-05-2024
- XFLT 01-01-0001
- Dividend Yield
- QURE N/A
- XFLT 14.17%
- EPS Growth
- QURE N/A
- XFLT N/A
- EPS
- QURE N/A
- XFLT N/A
- Revenue
- QURE $27,707,000.00
- XFLT N/A
- Revenue This Year
- QURE $187.60
- XFLT N/A
- Revenue Next Year
- QURE $51.90
- XFLT N/A
- P/E Ratio
- QURE N/A
- XFLT N/A
- Revenue Growth
- QURE N/A
- XFLT N/A
- 52 Week Low
- QURE $3.73
- XFLT $6.01
- 52 Week High
- QURE $11.35
- XFLT $7.76
- Technical
- Relative Strength Index (RSI)
- QURE 63.87
- XFLT 42.05
- Support Level
- QURE $6.01
- XFLT $6.81
- Resistance Level
- QURE $6.55
- XFLT $6.85
- Average True Range (ATR)
- QURE 0.54
- XFLT 0.04
- MACD
- QURE 0.18
- XFLT -0.00
- Stochastic Oscillator
- QURE 91.67
- XFLT 12.50
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About XFLT XAI Octagon Floating Rate & Alternative Income Term Trust of Beneficial Interest
XAI Octagon Floating Rate & Alternative Income Trust is a diversified, closed-end management investment company which primarily invests in a dynamically managed portfolio of floating-rate credit instruments and other structured credit investments within the private markets. The Trust's investment objective is to seek attractive total return with an emphasis on income generation across multiple stages of the credit cycle.